Capecitabine and oxaliplatin combined with bevacizumab are feasible for treating selected Japanese patients at least 75 years of age with metastatic colorectal cancer

被引：0
|
作者：
Yoshinori Munemoto
Mitsuro Kanda
Keiichiro Ishibashi
Taishi Hata
Michiya Kobayashi
Junichi Hasegawa
Mutsumi Fukunaga
Akinori Takagane
Toshio Otsuji
Yasuhiro Miyake
Michitaka Nagase
Junichi Sakamoto
Masaki Matsuoka
Koji Oba
Hideyuki Mishima
机构：
[1] Fukuiken Saiseikai Hospital,Department of Surgery
[2] Nagoya University Graduate School of Medicine,Department of Gastroenterological Surgery (Surgery II)
[3] Saitama Medical Center,Department of Digestive Tract and General Surgery
[4] Saitama Medical University,Department of Gastroenterological Surgery
[5] Osaka University Graduate School of Medicine,Department of Human Health and Medical Sciences
[6] Kochi Medical School,Department of Surgery
[7] Osaka Rosai Hospital,Department of Surgery
[8] Hyogo Prefectural Nishinomiya Hospital,Department of Internal Medicine
[9] Surgical Division,Department of Surgery
[10] Hakodate Goryoukaku Hospital,Department of Surgical Oncology
[11] Dongo Hospital,Department of Biostatistics
[12] Minoh City Hospital Gastrointestinal Research Center,undefined
[13] Gifu University Graduate School of Medicine,undefined
[14] Director,undefined
[15] Tokai Central Hospital,undefined
[16] Matsuoka Clinic,undefined
[17] School of Public Health,undefined
[18] Tokyo University Graduate School of Medicine,undefined
[19] Interfaculty Initiative in Information Studies,undefined
[20] Tokyo University,undefined
[21] Unit of Cancer Center,undefined
[22] Aichi Medical University,undefined
来源：
BMC Cancer | / 15卷
关键词：
Colorectal cancer; Elderly; Bevacizumab; XELOX;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Capecitabine and oxaliplatin (XELOX) in combination with bevacizumab in the treatment of metastatic colorectal cancer: results of a phase II trial
    Bendell, J.
    Yu, D.
    Hurwitz, H.
    Morse, M.
    Blobe, G.
    Gockerman, J.
    Odogwu, L.
    Mahon, M.
    Truax, R.
    Fernando, N.
    EJC SUPPLEMENTS, 2005, 3 (02): : 189 - 189
  • [22] EFFECT OF BEVACIZUMAB IN PATIENTS OVER 65 YEARS OF AGE WITH METASTATIC COLORECTAL CANCER (MCRC)
    Cassidy, J.
    Giantonio, B.
    Kabbinavar, F.
    Hurwitz, H.
    Rohr, U. P.
    Saltz, L. B.
    ANNALS OF ONCOLOGY, 2008, 19 : 125 - 125
  • [23] Combined treatment of oxaliplatin and capecitabine in patients with metastatic esophageal squamous cell cancer
    Tian-Jie Qin
    School of Medicine of Xi’an Jiaotong University
    World Journal of Gastroenterology, 2009, 15 (07) : 871 - 876
  • [24] Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205
    T Hoehler
    G von Wichert
    C Schimanski
    S Kanzler
    M H Moehler
    A Hinke
    T Seufferlein
    J Siebler
    A Hochhaus
    D Arnold
    M Hallek
    R Hofheinz
    U T Hacker
    British Journal of Cancer, 2013, 109 : 1408 - 1413
  • [25] Combined treatment of oxaliplatin and capecitabine in patients with metastatic esophageal squamous cell cancer
    Qin, Tian-Jie
    An, Gai-Li
    Zhao, Xin-Han
    Tian, Fang
    Li, Xiao-Hua
    Lian, Juan-Wen
    Pan, Bo-Rong
    Gu, Shan-Zhi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (07) : 871 - 876
  • [26] Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205
    Hoehler, T.
    von Wichert, G.
    Schimanski, C.
    Kanzler, S.
    Moehler, M. H.
    Hinke, A.
    Seufferlein, T.
    Siebler, J.
    Hochhaus, A.
    Arnold, D.
    Hallek, M.
    Hofheinz, R.
    Hacker, U. T.
    BRITISH JOURNAL OF CANCER, 2013, 109 (06) : 1408 - 1413
  • [27] The combination of capecitabine and irinotecan in treating 5-fluorouracil- and oxaliplatin-pretreated metastatic colorectal cancer
    Shin, Sang Joon
    Ahn, Joong Bae
    Choi, Hye Jin
    Cho, Byoung Chul
    Jeung, Hei-Cheul
    Rha, Sun Young
    Chung, Hyun Cheol
    Roh, Jae Kyung
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (01) : 75 - 81
  • [28] The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer
    Sang Joon Shin
    Joong Bae Ahn
    Hye Jin Choi
    Byoung Chul Cho
    Hei-Cheul Jeung
    Sun Young Rha
    Hyun Cheol Chung
    Jae Kyung Roh
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 75 - 81
  • [29] Should capecitabine replace infusional fluorouracil and leucovorin when combined with oxaliplatin in metastatic colorectal cancer?
    Mayer, Robert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (27) : 4165 - 4167
  • [30] A phase II study of oxaliplatin (OX), capecitabine (CAP), and bevacizumab (BV) in the treatment of metastatic colorectal cancer.
    Bendell, J. C.
    Fernando, N.
    Morse, M.
    Blobe, G.
    Yu, D.
    Sutton, L.
    Schaffer, S.
    Honeycutt, W.
    Franklin, A.
    Hurwitz, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 156S - 156S
12345